- conflicts or gaps
- [[{"field": "funding.total_equity_usd", "conflict": "Company press release (Nov 2017) reports $9.9M total equity raised; Tracxn reports $17M over 7 rounds with no primary-source confirmation of post-2017 equity", "source_urls": ["https://www.prnewswire.com/news-releases/perlara-announces-74m-equity-financing-300545859.html", "https://tracxn.com/d/companies/perlara-pbc/__aAqEnYJXP1CkY0WD5m6TjgeZVatgUDDi4pB-FOfl2lI"]}, {"field": "funding.rounds.stage", "conflict": "2017 $7.4M round labeled Series B by Tracxn; company PR does not assign a series name", "source_urls": ["https://tracxn.com/d/companies/perlara-pbc/__aAqEnYJXP1CkY0WD5m6TjgeZVatgUDDi4pB-FOfl2lI", "https://www.prnewswire.com/news-releases/perlara-announces-74m-equity-financing-300545859.html"]}, {"field": "identity.headquarters", "conflict": "YC lists Oakland, CA; LinkedIn and 2017 PR list South San Francisco; 2025 SBIR release lists Alameda, CA", "source_urls": ["https://www.ycombinator.com/companies/perlara", "https://www.linkedin.com/company/perlara-pbc", "https://www.prnewswire.com/news-releases/perlara-announces-74m-equity-financing-300545859.html", "https://www.einpresswire.com/article/864307336/perlara-pbc-awarded-1-7m-sbir-grant-to-fund-yeast-powered-drug-discovery-for-mitochondrial-diseases"]}, {"field": "employees.count", "conflict": "YC team_size=1 (stale); LinkedIn=11; Business Insider reported 15 FTE at 2019 peak; company describes distributed/fractional model since reboot", "source_urls": ["https://www.ycombinator.com/companies/perlara", "https://www.linkedin.com/company/perlara-pbc", "https://www.businessinsider.com/ethan-perlstein-shares-lessons-from-the-failure-of-biotech-perlara-2019-4", "https://perlara.substack.com/p/the-anti-portfolio-of-pharma"]}, {"field": "exit_status.status", "conflict": "March 2019 wind-down widely reported as company failure; company and YC currently list Active with Perlara 2.0/3.0 reboot rather than acquisition or shutdown", "source_urls": ["https://globalgenes.org/raredaily/perlara-to-wind-down-operations/", "https://www.businessinsider.com/ethan-perlstein-shares-lessons-from-the-failure-of-biotech-perlara-2019-4", "https://www.ycombinator.com/companies/perlara", "https://www.perlara.com/"]}, {"field": "founders", "gap": "Henry Perlstein confirmed co-founder in 2014 PR and founder blog; YC company page founder section did not list individual names in fetched snapshot; Tracxn lists both founders but is secondary", "source_urls": ["https://www.prnewswire.com/news-releases/perlstein-lab-raises-2-million-for-orphan-drug-discovery-269957791.html", "https://archive.perlara.com/blog/introducing-perlara/", "https://www.ycombinator.com/companies/perlara", "https://tracxn.com/d/companies/perlara-pbc/__aAqEnYJXP1CkY0WD5m6TjgeZVatgUDDi4pB-FOfl2lI"]}, {"field": "funding.novartis_equity", "gap": "Novartis equity amount never publicly disclosed", "source_urls": ["https://cen.acs.org/articles/94/i42/Perlara-signs-rare-disease-pact.html"]}, {"field": "funding.post_2017_equity", "gap": "No primary-source confirmation of equity rounds after Nov 2017; founder states bootstrapping since 2021", "source_urls": ["https://perlara.substack.com/p/the-anti-portfolio-of-pharma", "https://www.prnewswire.com/news-releases/perlara-announces-74m-equity-financing-300545859.html"]}, {"field": "funding.yc_investment_amount", "gap": "YC participation confirmed in 2017 round; YC investment dollar amount not found in fetched primary sources", "source_urls": ["https://www.prnewswire.com/news-releases/perlara-announces-74m-equity-financing-300545859.html", "https://www.ycombinator.com/companies/perlara"]}]]
- source urls
- ["https://archive.perlara.com/blog/introducing-perlara/", "https://cen.acs.org/articles/94/i42/Perlara-signs-rare-disease-pact.html", "https://globalgenes.org/raredaily/perlara-to-wind-down-operations/", "https://linkedin.com/in/henryperlstein", "https://perlara.substack.com/p/the-anti-portfolio-of-pharma", "https://tracxn.com/d/companies/perlara-pbc/__aAqEnYJXP1CkY0WD5m6TjgeZVatgUDDi4pB-FOfl2lI", "https://www.biospace.com/deals/shark-tank-billionaire-mark-cuban-invests-in-tiny-bay-area-biotech-perlara", "https://www.businessinsider.com/ethan-perlstein-shares-lessons-from-the-failure-of-biotech-perlara-2019-4", "https://www.einpresswire.com/article/864307336/perlara-pbc-awarded-1-7m-sbir-grant-to-fund-yeast-powered-drug-discovery-for-mitochondrial-diseases", "https://www.linkedin.com/company/perlara-pbc", "https://www.perlara.com/", "https://www.perlara.com/about", "https://www.prnewswire.com/news-releases/perlara-announces-74m-equity-financing-300545859.html", "https://www.prnewswire.com/news-releases/perlstein-lab-raises-2-million-for-orphan-drug-discovery-269957791.html", "https://www.ycombinator.com/blog/perlstein-lab-yc-w16-automates-drug-discovery-for-rare-diseases", "https://www.ycombinator.com/companies/perlara"]